Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.
Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
Sleep Disorders in Multiple Sclerosis.
[Guillain-Barré syndrome with dysphagia after frontal sinusitis.]
Single-step grafting of aminooxy-peptides to hyaluronan: A simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis.
Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.
Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease.
Association between OSA and Severe Fatigue in Patients with Multiple Sclerosis (MS).
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab.
Intramuscular IFNß-1a in multiple sclerosis: 'no proof of effectiveness' or 'proof of no effectiveness'?
Infiltration of CCR2+Ly6Chigh Proinflammatory Monocytes and Neutrophils into the Central Nervous System Is Modulated by Nicotinic Acetylcholine Receptors in a Model of Multiple Sclerosis.
Cerebral infarction following subcutaneous immunoglobulin therapy for chronic inflammatory demyelinating polyradiculoneuropathy.
A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report.
Magnetic susceptibility and isothermal remanent magnetization in human tissues: a study case.
Optic neuritis, the most common initial presenting manifestation of multiple sclerosis in northern Iran.
Seasonality of 278 neuromyelitis optica relapses in a Brazilian cohort.
B cells and progressive multifocal leukoencephalopathy: search for the missing link.
[The nurse's role in the post-diagnosis consultation].
A computer-based screening method for distress in patients with multiple sclerosis: a feasibility study.
Immune Rebound: Multiple Sclerosis after Treatment of Cushing's Disease.
Neuromyelitis optica does not impact periventricular venous density versus healthy controls: a 7.0 Tesla MRI clinical study.
Neurosarcoidosis: Clinical manifestations, diagnosis and treatment.
Reply to comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
condition Specific Utilities: Impact on Icer in a Markov Model for Multiple Sclerosis.
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.

Pages